China Growth Stocks

[Potse]

LHSI(1.50)...china pediatric pharma.....

1) Based on the RM press release, LHSI appears to be very much interested in uplisting to a higher exchange.....

http://ih.advfn.com/p.php?pid=nmona&cb=1255370245&article=39835481&symbol=NB%5ELHSI

2) Interesting to note that the sole compensation for the consultant and investor relations firm on this recent reverse merger comes in the form of warrants exercisable at a significant premium to the current share price ($3 and $5).

3) I've read through the warrant agreements several times, and unless I've completely overlooked something, there appears to be no cashless exercise option on those warrants.

So the consultant/IR on LHSI appear to be fairly confident in seeing much higher prices on this stock. IMO, buying some shares at a 50% discount to those warrant prices should be good for at least a double/triple.